We are live on
!
Find out more
CC
Capital Counsel Portfolio holdings
AUM
$2.35B
1-Year Est. Return
21.34%
This Fund
S&P 500
This Quarter
Est. Return
+9.55%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$2.13B
AUM Growth
+$351M
(+20%)
Cap. Flow
+$195M
Cap. Flow
% of AUM
9.15%
Top 10 Holdings %
Top 10 Hldgs %
57.71%
Holding
137
New
6
Increased
26
Reduced
40
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDK
CDK Global, Inc.
CDK
|
+$60.3M |
| 2 |
Ecolab
ECL
|
+$33.8M |
| 3 |
Visa
V
|
+$26.1M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$4.2M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$3.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Laboratories
CLB
|
+$39.2M |
| 2 |
Automatic Data Processing
ADP
|
+$21.4M |
| 3 |
FEIC
FEI COMPANY
FEIC
|
+$20.5M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$17.9M |
| 5 |
WEX
WEX
|
+$6.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.91% |
| 2 | Industrials | 23.8% |
| 3 | Financials | 11.71% |
| 4 | Technology | 9.88% |
| 5 | Consumer Staples | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESRX
1
DELISTED
Express Scripts Holding Company
ESRX
| $177M | 8.32% |
2,091,600
-56,774
| -3% | -$4.44M |
|
2
Mettler-Toledo International
MTD
$28.1B
| $165M | 7.73% |
544,053
-9,338
| -2% | -$2.57M |
|
|
3
Automatic Data Processing
ADP
$109B
| $140M | 6.56% |
1,674,052
-264,082
| -14% | -$21.4M |
|
4
Wabtec
WAB
$49.3B
| $139M | 6.53% |
1,600,433
-25,321
| -2% | -$2.13M |
|
5
Idexx Laboratories
IDXX
$44.9B
| $121M | 5.69% |
1,633,676
-27,276
| -2% | -$1.91M |
|
|
PCP
6
DELISTED
PRECISION CASTPARTS CORP
PCP
| $108M | 5.08% |
448,995
-8,214
| -2% | -$1.9M |
|
7
Donaldson
DCI
$10.7B
| $101M | 4.75% |
2,617,672
-45,374
| -2% | -$1.8M |
|
|
VAR
8
DELISTED
Varian Medical Systems, Inc.
VAR
| $96.3M | 4.52% |
1,269,847
-40,357
| -3% | -$3M |
|
|
9
Visa
V
$701B
| $87.6M | 4.11% |
1,335,888
+433,756
| +48% | +$26.1M |
|
10
CME Group
CME
$95.4B
| $83.7M | 3.93% |
944,096
-16,925
| -2% | -$1.43M |
|
|
AL
11
DELISTED
Air Lease Corp
AL
| $70.4M | 3.31% |
2,053,214
+32,050
| +2% | +$1.13M |
|
|
SIAL
12
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $70M | 3.29% |
509,806
-131,572
| -21% | -$17.9M |
|
|
CDK
13
DELISTED
CDK Global, Inc.
CDK
| $69.4M | 3.26% |
+1,701,952
| New | +$60.3M |
|
|
14
Ecolab
ECL
$79.8B
| $60.1M | 2.82% |
575,023
+309,059
| +116% | +$33.8M |
|
|
FEIC
15
DELISTED
FEI COMPANY
FEIC
| $50.1M | 2.35% |
554,017
-245,814
| -31% | -$20.5M |
|
16
Costco
COST
$432B
| $35.6M | 1.67% |
251,005
-627
| -0.2% | -$85.2K |
|
17
T. Rowe Price
TROW
$25.5B
| $32.5M | 1.53% |
378,529
-4,900
| -1% | -$399K |
|
|
18
Core Laboratories
CLB
$455M
| $31.1M | 1.46% |
258,466
-298,074
| -54% | -$39.2M |
|
19
AptarGroup
ATR
$8.69B
| $30.6M | 1.44% |
457,762
-2,326
| -0.5% | -$147K |
|
20
Intel
INTC
$413B
| $29M | 1.36% |
799,346
-7,125
| -0.9% | -$248K |
|
|
21
WEX
WEX
$6.42B
| $29M | 1.36% |
293,035
-65,500
| -18% | -$6.98M |
|
22
Berkshire Hathaway Class B
BRK.B
$1.1T
| $27.7M | 1.3% |
184,525
-430
| -0.2% | -$62.1K |
|
23
ExxonMobil
XOM
$650B
| $19.8M | 0.93% |
213,960
-2,219
| -1% | -$207K |
|
24
Coca-Cola
KO
$383B
| $13.7M | 0.65% |
325,505
-1,560
| -0.5% | -$66.6K |
|
25
Johnson & Johnson
JNJ
$640B
| $10.5M | 0.49% |
100,063
+150
| +0.2% | +$15.8K |
|
Similar funds
HFM
ROIC
EC
SCA
G
MC
BAM
BJL
Capital Counsel's Q4 2014 Portfolio in Review
As of Q4 2014, Capital Counsel held 137 positions worth $2.13B, up 20% from $1.78B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Capital Counsel deployed $195M of net new capital in Q4 2014, opening 6 new positions and adding to 26 existing holdings. Its largest new stake was CDK Global, Inc.: 1,701,952 shares worth $69.4M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Core Laboratories, an estimated $39.2M trimmed.
- Capital Counsel's largest Q4 2014 buy was CDK Global, Inc.: 1,701,952 shares worth $69.4M.
- Capital Counsel added most to Ecolab in Q4 2014, an estimated $33.8M increase.
- Capital Counsel's biggest Q4 2014 reduction was Core Laboratories, cutting an estimated $39.2M.
- Capital Counsel fully exited Fastenal in Q4 2014, selling an estimated $4.02M.
- Capital Counsel's ten largest holdings make up 58% of its $2.13B portfolio in Q4 2014.
- Capital Counsel opened 6 new positions and closed 7 in Q4 2014.
- Capital Counsel's portfolio value rose 20% quarter-over-quarter to $2.13B.
Based on Capital Counsel's 13F filing for Q4 2014, filed 11 Feb 2015.